Dynamic Purchasing System for Continuous and Repeated Purchases of Medicinal Products
Titre original de l'avis
Czechia – Pharmaceutical products – DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
30 / 100
Facteurs de risque
Failure to meet unspecified eligibility criteria or document requirements may lead to exclusion.
Potential inconsistency: structured data indicates EU funding, but XML notice suggests no EU funds. This may affect con...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Aperçu
Strong opportunityFaits clés
- CZK 2000M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration until Aug 2030
- Supply of pharmaceutical products (CPV 33600000) to the General University Hospital in Prague.
- Establishment of a Dynamic Purchasing System (DPS) for continuous and repeated purchases.
Afficher le résumé complet
The Všeobecná fakultní nemocnice v Praze (General University Hospital in Prague) is establishing a Dynamic Purchasing System (DPS) for the continuous and repeated supply of pharmaceutical products. The DPS will run from August 2022 to August 2030, with an estimated total value of CZK 2,000,000,000 (approx. EUR 82.7 million). The procedure is restricted, and the award will be based solely on the lowest price. The tender is open to all interested suppliers, and electronic submission is required. The only language allowed is Czech.
Risques
Failure to meet unspecified eligibility criteria or document requirements may lead to exclusion.
Potential inconsistency: structured data indicates EU funding, but XML notice suggests no EU funds. This may affect con...
Restricted procedure — pre-qualification required
L'analyse peut être incomplète
Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.
Exigences clés
Administrative
- Electronic submission via the buyer's profile at tenderarena.cz.
- All communication and submissions must be in Czech.
- Suppliers must meet the qualification criteria as detailed in the procurement documents.
Les exigences peuvent être incomplètes.
Critères d'attribution
Lot 1
Acheteur
Localisation
Praha, CZE
Site web
Profil acheteur
Identifiant
00064165
Activité
Health
Lots (1)
LOT-0001
Dynamic Purchasing System for Continuous and Repeated Purchases of Medicinal Products
This is the sole lot covering the entire DPS for the supply of medicinal products to the General University Hospital in Prague. The DPS is intended for the procurement of various pharmaceutical products over the duration of the system.
EUR 82.7M
Valeur estimée
Localisation
Durée
Catégorie
Critères d'attribution
Date limite
Détails des critères
Nejnižší nabídková cena
blíže viz výzva k podání nabídek na veřejnou zakázku v zavedeném DNS.
Note sur la valeur
Afficher les données TED originales
Titre original du lot
DYNAMICKÝ NÁKUPNÍ SYSTÉM PRO PRŮBĚŽNÉ A OPAKOVANÉ NÁKUPY LÉČIVÝCH PŘÍPRAVKŮ
Description TED originale
Zadavatel prostřednictvím tohoto zadávacího řízení zavádí dynamický nákupní systém dle § 138 a násl. zákona na dodávky léčivých přípravků do Všeobecné fakultní nemocnice v Praze; blíže viz zadávací podmínky.
Détails de la procédure
- Date de publication
- 27 May 2024
- Langues
- Czech
Métadonnées de référence
- Base juridique
- 32014L0024
Identifiants de référence
- ID de l'appel d'offres
- 309046-2024
Documents (1)
Appels d'offres similaires
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Score d'opportunité
Pourquoi ce score ?
Opportunité
60 / 100
Complexité
30 / 100
Facteurs de risque
Failure to meet unspecified eligibility criteria or document requirements may lead to exclusion.
Potential inconsistency: structured data indicates EU funding, but XML notice suggests no EU funds. This may affect con...
Restricted procedure — pre-qualification required
Analyse approfondie du portefeuille
Utilise:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications